Stoke Therapeutics Earnings
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.88
Stoke Therapeutics earnings summary
Stoke Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.88. In its most recent report on Aug 3, 2026 (Q2 2026), STOK posted EPS of $-0.93. Revenue for the quarter was $9.3 million.
Across the last 16 reports, STOK shares moved an average of 7.1% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
STOK earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $-0.93 | — | -4.4% |
| May 7, 2026 | — | $-0.79 | — | -8.5% |
| Mar 16, 2026 | — | $-0.97 | — | -2.0% |
| Nov 4, 2025 | — | $-0.65 | — | +16.0% |
| Aug 12, 2025 | — | $-0.40 | — | +7.4% |
| May 13, 2025 | — | $1.90 | — | -4.1% |
| Mar 18, 2025 | — | $-0.15 | — | -11.5% |
| Nov 5, 2024 | — | $-0.47 | — | -13.3% |
| Aug 7, 2024 | — | $-0.46 | — | +1.5% |
| May 6, 2024 | — | $-0.57 | — | +21.1% |
| Mar 25, 2024 | — | $-0.61 | — | -6.9% |
| Nov 7, 2023 | — | $-0.55 | — | -0.9% |
| Aug 7, 2023 | — | $-0.69 | — | +0.7% |
| May 4, 2023 | — | $-0.53 | — | -4.3% |
| Mar 6, 2023 | — | $-0.65 | — | +2.1% |
| Nov 14, 2022 | — | $-0.66 | — | -8.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.